Ferretti, A.; Simeoli, R.; Cairoli, S.; Pietrafusa, N.; Trivisano, M.; Dionisi Vici, C.; Specchio, N.; Goffredo, B.M.
Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic Variants. Pharmaceutics 2022, 14, 2230.
https://doi.org/10.3390/pharmaceutics14102230
AMA Style
Ferretti A, Simeoli R, Cairoli S, Pietrafusa N, Trivisano M, Dionisi Vici C, Specchio N, Goffredo BM.
Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic Variants. Pharmaceutics. 2022; 14(10):2230.
https://doi.org/10.3390/pharmaceutics14102230
Chicago/Turabian Style
Ferretti, Alessandro, Raffaele Simeoli, Sara Cairoli, Nicola Pietrafusa, Marina Trivisano, Carlo Dionisi Vici, Nicola Specchio, and Bianca Maria Goffredo.
2022. "Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic Variants" Pharmaceutics 14, no. 10: 2230.
https://doi.org/10.3390/pharmaceutics14102230
APA Style
Ferretti, A., Simeoli, R., Cairoli, S., Pietrafusa, N., Trivisano, M., Dionisi Vici, C., Specchio, N., & Goffredo, B. M.
(2022). Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic Variants. Pharmaceutics, 14(10), 2230.
https://doi.org/10.3390/pharmaceutics14102230